Dose- and schedule-dependent inhibition of the mammalian target of rapamycin pathway with everolimus: a phase I tumor pharmacodynamic study in patients with advanced solid tumors. (Q46708758)
Jump to navigation
Jump to search
scientific article published on 10 March 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dose- and schedule-dependent inhibition of the mammalian target of rapamycin pathway with everolimus: a phase I tumor pharmacodynamic study in patients with advanced solid tumors. |
scientific article published on 10 March 2008 |
Statements
Dose- and schedule-dependent inhibition of the mammalian target of rapamycin pathway with everolimus: a phase I tumor pharmacodynamic study in patients with advanced solid tumors (English)
Federico Rojo
Emiliano Calvo
Howard Burris
Ian Judson
Katharine Hazell
Erika Martinelli
Suzanne Jones
Laura Vidal
Nicholas Shand
Teresa Macarulla
Sasa Dimitrijevic
Ulrike Zoellner
Pui Tang
Michael Stumm
Heidi A Lane
David Lebwohl
José Baselga